Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-collagen proteins in the extracellular matrix (ECM) refer to a diverse set of proteins other than collagens that are present within the ECM, a complex network of macromolecules surrounding and supporting cells in tissues. Major non-collagen ECM proteins include elastin, fibronectin, laminins, nidogen/entactin, proteoglycans (e.g., perlecan, decorin, biglycan, lumican), and glycosaminoglycans (GAGs) such as hyaluronic acid. These proteins contribute essential functions to the ECM, providing elasticity (elastin), mediating cell adhesion and signaling (fibronectin, laminins), establishing matrix structure and organization (nidogen, proteoglycans), and facilitating hydration and tissue resilience (GAGs)[1][2][3][5]. Non-collagen proteins also play critical regulatory roles in processes such as cell proliferation, migration, differentiation, and apoptosis, and in storing or presenting growth factors[1][5]. Dysregulation or mutation in these proteins is associated with various human diseases including inherited connective tissue disorders, cancer progression, and fibrosis[5][6]. 'Non-collagen proteins in extracellular matrix' is not a specific molecular target but rather a category or grouping of many distinct proteins within the ECM. Note: - The term "Non-collagen proteins in extracellular matrix" does not refer to a single defined molecule, receptor, or typical drug target, but rather a heterogeneous group encompassing many distinct protein species, each with unique structure and function[1][5]. - Targeting this category is not possible as a whole; specific drug development or biomarker research focuses on individual non-collagen ECM proteins (e.g., fibronectin, laminins, elastin, or specific proteoglycans) rather than the group collectively. - Therefore, this entry is marked as is_incorrect: true, as it does not conform to the convention of a precise, actionable biomolecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-collagen protein in extracellular matrix.